STERNA BIOLOG GMBH & CO KG has a total of 12 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), Canada and Germany. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are NAKAJIMA TOSHIHIRO, ADIPOGENIX INC and NEURO THERAPEUTICS AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Canada | 2 | |
#3 | Germany | 2 | |
#4 | Japan | 1 | |
#5 | Republic of Korea | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Measuring microorganism processes | |
#5 | Analysing materials | |
#6 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Schmidts Thomas | 4 |
#2 | Bille Joachim | 3 |
#3 | Turowska Agnieszka | 3 |
#4 | Runkel Frank | 3 |
#5 | Renz Harald | 2 |
#6 | Sel Serdar | 2 |
#7 | Garn Holger | 1 |
#8 | Turowska Agnieszka Dr | 1 |
#9 | Renz Harald Prof Dr | 1 |
#10 | Sel Serdar Dr | 1 |
Publication | Filing date | Title |
---|---|---|
EP2708898A1 | Method for diagnosing a molecular phenotype of a patient suffering from an illness related to chronic inflammation | |
DE102011109868A1 | Multiple emulsion | |
DE102010007562A1 | Dermatological, pharmaceutical composition suitable for oligonucleotides |